Login | Register

Lung cancer drug doing well in smoker trial



Early results of a trial testing the safety of a new type of drug that helps the immune system attack cancer cells is showing promising results in lung cancer patients, especially in those who are smokers or former smokers. The experimental drug, called MPDL3280A (made by Roche), is being tested in patients with non-small cell lung cancer (NSCLC)…

Leave a Reply

Your email address will not be published. Required fields are marked *